Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
With
Fundación Mutua Madrileña
Transversal study design like a "proof of concept".
Primary objective:
The main objective is try to stablish a descriptive panel (first phase of a score system) based in the conjunction or sum of several clinical and laboratory parameters (molecular and genetic factors). The aim is to detect in a fast, early and successful way those patients that presents a high risk to develop an hepatocellular carcinoma (HCC) in the future in a specific population: HIV and HCV coinfected patients. The establishment of this panel will allow clinicians set up a correct treatment decreasing the probability of liver cirrhosis and HCC.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Human immunodeficiency virus chronic infection
Hepatitis C virus chronic infection
No other liver viral coinfections
You may not be if
Alcohol consume
Immunosuppressor or immunoactive treatment
Clareo Health | Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients